Skip to main content
SpringerLink
Log in

Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis

  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Most cirrhotic patients with hepatocellular carcinoma (HCC) are not candidates for resection. Transarterial chemoembolization (TACE) may ablate a significant portion of the tumor but has a high rate of recurrence. Cryosurgery may permit successful ablation of hepatic tumors but can be complicated by post-operative hemorrhage and is also associated with a significant risk of recurrence. The combination of the two techniques might be beneficial. We evaluated in a prospective study the safety and efficacy of this combination in cirrhotic patients with unresectable HCC. Fifteen patients were included in this study. All but one patient underwent one or several sessions of TACE before cryosurgery. Cryoablation was successfully performed in each patient. The patient who did not undergo preoperative TACE required reoperation for hemorrhage. Another patient with Child-Pugh class B cirrhosis died postoperatively of hepatic and multiorgan failure. At a mean follow-up of 2.5 years, three patients had recurrence of disease, and 13 of 15 patients were alive with the longest survival time being 5 years. The actuarial survival rate at 5 years was 79%. Cryosurgery after TACE is feasible in cirrhotic livers with HCC and can increase the cure rate in large tumors. TACE may reduce the risk of hemorrhage after cryosurgery but can increase the risk of hepatic failure in patients with poor hepatic function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rustgi VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 1987; 16:545–551.

    PubMed  CAS  Google Scholar 

  2. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: A Western experi ence. Hepatogastroenterology 1998;45:1281–1287.

    PubMed  Google Scholar 

  3. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A. No-mortality liver re section for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients: Is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984–992.

    Article  PubMed  CAS  Google Scholar 

  4. Di Carlo V, Ferrari G, Castoldi R. Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics. Hepatogastroenterology 1995;42:222–229.

    PubMed  Google Scholar 

  5. Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El-Assal ON. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg 1999;229:84–90.

    Article  PubMed  CAS  Google Scholar 

  6. Gozzetti G, Mazziotti A, Cavallari A, Bellusci R, Bolondi L, Grigioni W, Bragaglia R, Grazi GL, De Raffele E. Clinical experience with hepatic resections for hepatocellular carci noma in patients with cirrhosis. Surg Gynecol Obstet 1988;166:503–510.

    PubMed  CAS  Google Scholar 

  7. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortal ity of major hepatectomy for hepatocellular carcinoma asso ciated with cirrhosis. Arch Surg 1995;130:198–203.

    PubMed  CAS  Google Scholar 

  8. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, Yukaya H. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217:375–384.

    Article  PubMed  CAS  Google Scholar 

  9. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term out come after hepatic resection for hepatocellular carcinoma. AmJ Surg 1995;169:28–35.

    Article  CAS  Google Scholar 

  10. Di Carlo V, Ferrari G, Castoldi R. Preoperative chemoem-bolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 1998;45:1950–1954.

    PubMed  Google Scholar 

  11. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Cioni R, Mazzeo S, Carrai M, Maltinti G, Capria A, Conte PF. Treatment of large HCC: Transcatheter arterial chemoem-bolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995;197:812–818.

    PubMed  CAS  Google Scholar 

  12. Kohli V, Clavien PA. Cryoablation of liver tumours. Br J Surg 1998;85:1171–1172.

    Article  PubMed  CAS  Google Scholar 

  13. Dutta P, Montes M, Gage AA. Large volume freezing in ex perimental hepatic cryosurgery. Avoidance of bleeding in hepatic freezing by an improvement in the technique. Cryobiology 1979;16:50–55.

    Article  PubMed  CAS  Google Scholar 

  14. Wren SM, Coburn MM, Tan M, Daniels JR, Yassa N, Carpenter CL, Stain SC. Is cryosurgical ablation appropriate for treating hepatocellular cancer? Arch Surg 1997;132:599–604.

    PubMed  CAS  Google Scholar 

  15. Wong LL, Limm WM, Cheung AH, Fan FL, Wong LM. Hepatic cryosurgery: Early experience in Hawaii. Hawaii MedJ 1995;54:811–813.

    CAS  Google Scholar 

  16. Clavien PA. Malignant Liver Tumors: Cryoablation of Liver Tumors. New York: Blackwell Science, 1999, pp 159–169.

    Google Scholar 

  17. Wong WS, Patel SC, Cruz FS, Gala KV, Turner AF. Cryo surgery as a treatment for advanced stage hepatocellular carcinoma: Results, complications, and alcohol ablation. Cancer 1998;82:1268–1278.

    Article  PubMed  CAS  Google Scholar 

  18. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malig nant liver tumors. Ann Surg 1997;225:39–50.

    Article  PubMed  CAS  Google Scholar 

  19. Crews KA, Kuhn JA, McCarty TM, Fisher TL, Goldstein RM, Preskitt JT. Cryosurgical ablation of hepatic tumors. AmJ Surg 1997;174:614–618.

    Article  CAS  Google Scholar 

  20. Horiguchi Y, Sekoguchi B, Imai H, Suzuki T, Kubo H, Itoh H, Itoh M. Treatment of choice for unresectable small liver cancer: Percutaneous ethanol injection therapy or transarterial chemoembolization therapy. Cancer Chemother Phar macol 1994;33:S111-S114.

    Article  Google Scholar 

  21. Lencioni R, Paolicchi A, Moretti M, Paolicchi A, Moretti M, Cioni D, Donati F, Cicorelli A, Ricci S, Carrai M, Conte PF, Cavina E, Bartolozzi C. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: Local therapeutic effect and long-term survival rate. Eur Radiol 1998;8:439–444.

    Article  PubMed  CAS  Google Scholar 

  22. Tanaka K, Nakamura S, Numata K. The long term efficacy of combined transcatheter arterial embolization and percutane ous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998;82:78–85.

    Article  PubMed  CAS  Google Scholar 

  23. Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Roh MS, Granchi J, Curley SA. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592–599.

    Article  PubMed  CAS  Google Scholar 

  24. Zhou XD, Tang ZY, Yu YQ, Weng JM, Ma ZC, Zhang BH, Zheng YX. The role of cryosurgery in the treatment of hepatic cancer: A report of 113 cases. J Cancer Res Clin Oncol 1993;120:100–102.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Duke University Medical Center, Durham, North Carolina

    Pierre-Alain Clavien M.D., Ph.D., F.A.C.S. (Professor and Chairman), Koo Jeong Kang M.D. & Nazia Selzner M.D.

  2. Division of Hepatobiliary Surgery and Liver Transplantation, Department of Medicine, Duke University Medical Center, Durham, North Carolina

    Michael A. Morse M.D.

  3. Division of Hepatobiliary Surgery and Liver Transplantation, Department of Radiology, Duke University Medical Center, Durham, North Carolina

    Pierre-Alain Clavien M.D., Ph.D., F.A.C.S. (Professor and Chairman)

  4. Department of Visceral and Transplantation Surgery, Zurich University Hospital, Zurich, Switzerland

    Pierre-Alain Clavien M.D., Ph.D., F.A.C.S. (Professor and Chairman), Nazia Selzner M.D. & Paul V. Suhocki M.D.

Authors
  1. Pierre-Alain Clavien M.D., Ph.D., F.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koo Jeong Kang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nazia Selzner M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael A. Morse M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paul V. Suhocki M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierre-Alain Clavien M.D., Ph.D., F.A.C.S..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clavien, PA., Kang, K.J., Selzner, N. et al. Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis. J Gastrointest Surg 6, 95–101 (2002). https://doi.org/10.1016/S1091-255X(01)00037-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(01)00037-3

Key words

Search

Navigation